GUARDION HEALTH SCIENCES INC (GHSI)

Company Profile

Guardion Health Sciences, Inc. engages in the business of developing and distributing clinically supported nutrition, medical foods, and dietary supplements. The company is headquartered in Houston, Texas and currently employs 9 full-time employees. The company went IPO on 2019-04-05. The firm offers a portfolio of science-based, clinically supported products designed to support the health needs of consumers, healthcare professionals and providers and their patients. The firm sells two ocular products: GlaucoCetin and Lumega-Z. GlaucoCetin is a dietary supplement in a capsule form designed specifically to provide nutrients to support mitochondrial function with additional antioxidants to help reduce oxidative stress and increase blood flow throughout the body for enhanced eye support and ocular health. Lumega-Z, its medical food product, has a formula designed to replenish and restore the macular protective pigment, simultaneously delivering critical and essential nutrients to the eye. As a medical food, Lumega-Z must be administered under the supervision of a physician or professional healthcare provider. The company sells GlaucoCetin and Lumega-Z on its Website, guardionhealth.com.

Company Info

GUARDION HEALTH SCIENCES INC

2925 Richmond Avenue, Suite 1200

Houston TEXAS 92128

P: 18008735141

CEO: Bret Scholtes

Employees: 9

Website: https://www.guardionhealth.com/